Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Int Med Res. 2013 Aug;41(4):1228-35. doi: 10.1177/0300060513487631. Epub 2013 Jun 25.

The role of insulin-like growth factor 1 and its receptor in the formation and development of colorectal carcinoma.

Author information

  • 1State Key Laboratory of Oncology in Southern China, Guangzhou, China.

Abstract

OBJECTIVE:

To investigate the role of insulin-like growth factor (IGF)-1 and its receptor (IGF1R) in the formation and development of colorectal carcinoma.

METHODS:

Colorectal tissue and matching serum samples were collected from patients with adenomatous polyps or carcinoma and healthy control subjects. IGF1R mRNA levels were determined via quantitative real-time reverse transcription-polymerase chain reaction. Serum IGF1 was quantified using enzyme-linked immunosorbent assay.

RESULTS:

Serum IGF1 concentrations and mucosal IGF1R mRNA levels were significantly higher in patients with adenomatous polyps (n = 24) or carcinoma (n = 13) compared with healthy control subjects (n = 13). There was a significant positive correlation between serum IGF1 and mucosal IGF1R mRNA in patients with adenomatous polyps.

CONCLUSIONS:

High circulating IGF1 concentrations and mucosal IGF1R expression may play important roles in both the formation and development of colorectal carcinoma. IGF1 and its receptor may be activated before carcinogenesis, and may promote the growth and malignant transformation of adenomatous polyps. IGF1 and IGF1R may be useful biomarkers for evaluating the stage and risk of carcinogenesis.

KEYWORDS:

Insulin-like growth factor 1; colorectal carcinoma; colorectal polyps; enzyme-linked immunosorbent assay; insulin-like growth factor receptor; quantitative real-time RT–PCR

PMID:
23801064
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk